Stockscreener 앱 받기
3.19
1.92%
0.06
시간 외 거래:
3.13
-0.06
-1.88%
전일 마감가:
$3.13
열려 있는:
$3.12
하루 거래량:
22,114
Relative Volume:
0.03
시가총액:
$7.23M
수익:
-
순이익/손실:
$-12.88M
주가수익비율:
-1.3741
EPS:
-2.3215
순현금흐름:
$-10.85M
1주 성능:
-1.54%
1개월 성능:
-18.62%
6개월 성능:
-47.45%
1년 성능:
-79.14%
1일 변동 폭
$3.10
$3.19
1주일 범위
$3.00
$3.4799
52주 변동 폭
$2.7375
$20.22
프로세사 파마슈티컬스 Stock (PCSA) Company Profile
명칭
Processa Pharmaceuticals Inc
전화
443-776-3133
주소
601 21ST STREET, SUITE 300, VERO BEACH
PCSA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PCSA
Processa Pharmaceuticals Inc
|
3.19 | 7.09M | 0 | -12.88M | -10.85M | -2.3215 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
프로세사 파마슈티컬스 Stock (PCSA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-04-25 | 개시 | H.C. Wainwright | Buy |
프로세사 파마슈티컬스 주식(PCSA)의 최신 뉴스
ETF Watch: Will Processa Pharmaceuticals Inc benefit from current market trendsQuarterly Trade Review & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Alliance Entertainment and Processa Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - lcsun-news.com
Processa Pharmaceuticals and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - recordonline.com
Risk Hedge: Is Processa Pharmaceuticals Inc showing insider buyingRate Cut & Step-by-Step Swing Trade Plans - baoquankhu1.vn
Processa Pharmaceuticals completes enrollment of 20th patient in Phase 2 study - MSN
Will Processa Pharmaceuticals Inc. benefit from current market trendsBull Run & AI Enhanced Execution Alerts - bollywoodhelpline.com
Stock Recap: Is Processa Pharmaceuticals Inc showing insider buying2025 Market WrapUp & Real-Time Market Sentiment Reports - baoquankhu1.vn
Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference to Discuss NGC-Cap Phase 2 Study Results - Quiver Quantitative
Breast cancer trial data in focus as Processa joins major health event - Stock Titan
Is Processa Pharmaceuticals Inc. stock supported by strong cash flowsMarket Risk Report & Fast Gain Swing Trade Alerts - ulpravda.ru
How Processa Pharmaceuticals Inc. stock reacts to oil pricesWeekly Gains Summary & Technical Buy Zone Confirmation - Улправда
User - FinancialContent
Will Processa Pharmaceuticals Inc. stock outperform value stocksLayoff News & Capital Efficiency Focused Strategies - Улправда
Biostar Pharmaceuticals (OTCMKTS:BSPM) versus Heatwurx (NASDAQ:PCSA) Critical Review - Defense World
Processa Pharmaceuticals Regains Nasdaq Minimum Bid Compliance - TipRanks
Processa Pharmaceuticals shares surge on encouraging cancer trial update - MSN
Processa Pharmaceuticals completes enrollment for NGC-Cap breast cancer study - Investing.com Nigeria
Processa Pharmaceuticals (PCSA) Advances in Phase 2 Cancer Study - GuruFocus
Processa Pharmaceuticals completes enrollment for NGC-Cap breast cancer study By Investing.com - Investing.com South Africa
Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study - The Manila Times
Processa Pharmaceuticals Inc. (PCSA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
User | chroniclejournal.comProcessa Pharmaceuticals, Inc.Common Stock (Nasdaq:PCSA) Stock Quote - FinancialContent
Why did Processa Pharmaceuticals stock surge 160% today? - MSN
프로세사 파마슈티컬스 (PCSA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.09%
0.48%
자본화:
|
볼륨(24시간):